• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
OPT

OPTHEA LIMITED

0.00% ! 60.0¢
Market Cap $820.7M  !

Opthea Limited is an Australia-based clinical-stage biopharmaceutical company. The... Opthea Limited is an Australia-based clinical-stage biopharmaceutical company. The Company is engaged in developing novel therapies to address the unmet need in the treatment of prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME). Its lead product candidate, sozinibercept (OPT-302), is being evaluated in two pivotal Phase 3 clinical trials for use in combination with standard-of-care anti-VEGF-A monotherapies for the treatment of wet AMD and DME. The Company has also manufactured OPT-302 for use in Phase III clinical trials, conducts activities to support the commercialization of the product and expanded its management team in the United States to facilitate broader oversight and execution of its Phase III program. Its development activities are based on an intellectual property portfolio covering key targets (Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3).More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
OPT 20/08/25 73 13K
20/08/25 Last post  Ollie3039 Comments Created with Sketch.  73  Views Created with Sketch.  13K 
OPT 20/08/25 5 1.1K
20/08/25 Last post  Paul Dong Comments Created with Sketch.  5  Views Created with Sketch.  1.1K 
OPT
The DFA Discussion
2
19/08/25 106 47K
19/08/25 Last post  Ollie3039 Comments Created with Sketch.  106  Views Created with Sketch.  47K 
OPT 19/08/25 0 267
19/08/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  267 
OPT 12/08/25 11 3.7K
12/08/25 Last post  slambo Comments Created with Sketch.  11  Views Created with Sketch.  3.7K 
OPT 03/08/25 667 249K
03/08/25 Last post  Ollie3039 Comments Created with Sketch.  667  Views Created with Sketch.  249K 
OPT 03/08/25 14 5.9K
03/08/25 Last post  FreeFromStyle Comments Created with Sketch.  14  Views Created with Sketch.  5.9K 
OPT 23/07/25 3 2.9K
23/07/25 Last post  TONFRA Comments Created with Sketch.  3  Views Created with Sketch.  2.9K 

See All Discussions arrow Created with Sketch.

Timeline

Corporate Update Investor Call
20 Aug 09:02
 
Application for quotation of securities - OPT
19 Aug 11:43
 
Opthea Provides Corporate Update
19 Aug 08:39
 
Application for quotation of securities - OPT
08 Aug 18:03
 
Quarterly Activities/Appendix 4C Cash Flow Report
30 Jul 08:29
 
Long Term Suspended Entities
16 Jul 16:15
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
60.0¢
Change
0.000(0.00%)
Mkt cap ! $820.7M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
OPT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.